Cms-10434 #26 Aqm2018-pc03 Ad

Centers for Medicare & Medicaid
Services
CMS eXpedited Life Cycle (XLC)

Medicaid and CHIP Program (MACPro)
AQM 2018 - Antenatal Steroids (PC03-AD) Core
Measure PRA document
Version 1.0
09/05/2018

Document Number: 463-QSSI-MACPro-PRA-AQM2018-PC03-AD-D
Contract Number: HHSM-500-2007-00024I: HHSM-500-T0014

CMS XLC

Table of Contents
1. Antenatal Steroids (PC03-AD) Core Measure – Screenshots .................................. 1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
1.10
1.11
1.12

Are you reporting on this measure? ........................................................................ 1
Measurement Specification – Path 1 ...................................................................... 1
Measurement Specification – Path 2 ...................................................................... 1
Data Source ................................................................................................................ 2
Date Range ................................................................................................................. 2
Definition of Population Included in the Measure .................................................. 3
Performance Measure ............................................................................................... 3
Deviations from Measurement Specifications ....................................................... 4
Combined Rate(s) from Multiple Reporting Units ................................................. 4
Additional Notes/Comments on Measure ............................................................... 4
Optional Measure Stratification – Screenshot 1 .................................................... 5
Optional Measure Stratification – Screenshot 2 .................................................... 5

Appendix A:

Acronyms .................................................................................................... 6

List of Figures
Figure 1: Are you reporting on this measure? ......................................................................... 1
Figure 2: Measurement Specification – Path 1 ....................................................................... 1
Figure 3: Measurement Specification – Path 2 ....................................................................... 1
Figure 4: Data Source ................................................................................................................. 2
Figure 5: Date Range .................................................................................................................. 2
Figure 6: Definition of Population Included in the Measure ................................................... 3
Figure 7: Performance Measure ................................................................................................ 3
Figure 8: Deviations from Measurement Specifications......................................................... 4
Figure 9: Combined Rate(s) from Multiple Reporting Units ................................................... 4
Figure 10: Additional Notes/Comments on Measure .............................................................. 4
Figure 11: Optional Measure Stratification – 1 ........................................................................ 5
Figure 12: Optional Measure Stratification – 2 ........................................................................ 5

AQM 2018 - Antenatal Steroids (PC03-AD) Core Measure PRA document
Version 1.0
i

09/05/2018

CMS XLC

List of Tables
Table 1: Acronyms ....................................................................................................................... 6

AQM 2018 - Antenatal Steroids (PC03-AD) Core Measure PRA document
Version 1.0
ii

09/05/2018

CMS XLC

Antenatal Steroids (PC03-AD) Core Measure – Screenshots

1. Antenatal Steroids (PC03-AD) Core Measure –
Screenshots
1.1

Are you reporting on this measure?

Figure 1: Are you reporting on this measure?

1.2

Measurement Specification – Path 1

Figure 2: Measurement Specification – Path 1

1.3

Measurement Specification – Path 2

Figure 3: Measurement Specification – Path 2

AQM 2018 - Antenatal Steroids (PC03-AD) Core Measure PRA document
Version 1.0
1

09/05/2018

CMS XLC

1.4

Antenatal Steroids (PC03-AD) Core Measure – Screenshots

Data Source

Figure 4: Data Source

1.5

Date Range

Figure 5: Date Range

AQM 2018 - Antenatal Steroids (PC03-AD) Core Measure PRA document
Version 1.0
2

09/05/2018

CMS XLC

1.6

Antenatal Steroids (PC03-AD) Core Measure – Screenshots

Definition of Population Included in the Measure

Figure 6: Definition of Population Included in the Measure

1.7

Performance Measure

Figure 7: Performance Measure

AQM 2018 - Antenatal Steroids (PC03-AD) Core Measure PRA document
Version 1.0
3

09/05/2018

CMS XLC

1.8

Antenatal Steroids (PC03-AD) Core Measure – Screenshots

Deviations from Measurement Specifications

Figure 8: Deviations from Measurement Specifications

1.9

Combined Rate(s) from Multiple Reporting Units

Figure 9: Combined Rate(s) from Multiple Reporting Units

1.10 Additional Notes/Comments on Measure

Figure 10: Additional Notes/Comments on Measure

AQM 2018 - Antenatal Steroids (PC03-AD) Core Measure PRA document
Version 1.0
4

09/05/2018

CMS XLC

Antenatal Steroids (PC03-AD) Core Measure – Screenshots

1.11 Optional Measure Stratification – Screenshot 1
Note: Same N/D/R sets are displayed under each of the stratification categories.

Figure 11: Optional Measure Stratification – 1

1.12 Optional Measure Stratification – Screenshot 2
Note: Same N/D/R sets are displayed under each of the stratification categories.

Figure 12: Optional Measure Stratification – 2

AQM 2018 - Antenatal Steroids (PC03-AD) Core Measure PRA document
Version 1.0
5

09/05/2018

CMS XLC

Antenatal Steroids (PC03-AD) Core Measure – Screenshots

Appendix A: Acronyms
Table 1: Acronyms
Acronym

Literal Translation

AQM

Adult Quality Measure

PRA

Paper Reduction Act of 1995

AQM 2018 - Antenatal Steroids (PC03-AD) Core Measure PRA document
Version 1.0
6

09/05/2018